![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/5377 | |
C07D 471/04 | |||
A61P 25/24 |
(11) | Number of the document | 2854814 |
(13) | Kind of document | T |
(96) | European patent application number | 13793417.0 |
Date of filing the European patent application | 2013-05-24 | |
(97) | Date of publication of the European application | 2015-04-08 |
(45) | Date of publication and mention of the grant of the patent | 2018-01-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/042732 |
Date | 2013-05-24 |
(87) | Number | WO 2013/177559 |
Date | 2013-11-28 |
(30) | Number | Date | Country code |
201261651669 P | 2012-05-25 | US | |
201261691083 P | 2012-08-20 | US | |
201261715907 P | 2012-10-19 | US | |
201361759520 P | 2013-02-01 | US | |
201361781629 P | 2013-03-14 | US |
(72) |
HUNT, Hazel, GB
JOHNSON, Tony, GB
RAY, Nicholas, GB
WALTERS, Iain, GB
|
(73) |
Corcept Therapeutics, Inc.,
149 Commonwealth Drive, Menlo Park CA 94025,
US
|
(54) | HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |
HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |